+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A new boron compound (guanidine biboric acid adduct) as an antitumour agent against Ehrlich ascites carcinoma in mice



A new boron compound (guanidine biboric acid adduct) as an antitumour agent against Ehrlich ascites carcinoma in mice



Tumour Biology 20(1): 44-51



The inhibitory effects of a new boron compound of guanidine biboric acid adduct (GB) and guanidium chloride (L1) on the growth of ascites tumour in female Swiss mice were studied by monitoring the survival, tumour weight, tumour cell count, transplantability of Ehrlich ascites cells, precursor incorporation and the haematological parameters of the treated mice. 5-Fluorouracil, a known anticancer drug, was used as a positive control. The most important parameter was the survival time, which increased significantly when tumour-bearing mice were treated with the boron compound. Haematological parameters of the treated animals showed minimum toxic effects when boron was coupled with guanidine.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 045079119

Download citation: RISBibTeXText

PMID: 9858874


Related references

A new boron compound (Guanidine Biboric Acid Adduct) as an antitumour agent against Ehrlich ascites carcinoma in mice. Tumor Biology 20(1): 44-51, 1999

On the possible use of a new boron compound, hydroxysalicylhydroxamato boron(III), and ultrasound in the treatment of female mice bearing the Ehrlich ascites carcinoma cells. Neoplasma 45(6): 384-388, 1998

On the possible use of a new boron compound, hydroxysalicylhydroxamato boron(III), and ultrasound in the treatment of female mice bearing the Ehrlich ascites carcinoma cells. Neoplasma 45(6): 384-388, 1999

Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice. Neoplasma 44(3): 197-201, 1997

Antitumour activity of Bauhinia variegata against Ehrlich ascites carcinoma induced mice. Pharmaceutical Biology 41(8): 604-607, 2003

Antitumour activity of Terminalia arjuna leaf against Ehrlich ascites carcinoma in mice. Natural Product Research 26(12): 1141-1144, 2012

Antitumour activity of Prosopis cineraria (L.) Druce against Ehrlich ascites carcinoma-induced mice. Natural Product Research 25(8): 857-862, 2011

Antitumour and antioxidant activity of Scutia myrtina against Ehrlich ascites carcinoma in Swiss albino mice. Natural Product Research 26(16): 1504-1509, 2012

Verapamil enhancement of the antitumour effect of cis-diamminedichloroplatinum (II) in mice bearing Ehrlich ascites carcinoma cells. Medical Science Research 24(6): 429-431, 1996

Antitumour effect of Diospyros cordifolia bark on Ehrlich ascites carcinoma-bearing Swiss albino mice. Natural Product Research 26(17): 1631-1633, 2012

Evaluation of antitumour activity ofCalotropis giganteaL root bark against Ehrlich ascites carcinoma in Swiss albino mice. 2011

Evaluation of antitumour activity of Calotropis gigantea L. root bark against Ehrlich ascites carcinoma in Swiss albino mice. Asian Pacific Journal of Tropical Medicine 4(10): 786-790, 2012

Synthesis, characterization of diorganotin(IV) complexes of N-(2-hydroxyarylidene)amino-acetic acid and antitumour screening in vivo in Ehrlich ascites carcinoma cells. Applied Organometallic Chemistry 15(12): 947-953, 2001

Antitumor properties of boron complexes with hydroxy biguanide and salicyl hydroxamic acid against Ehrlich ascites carcinoma. Neoplasma 45(2): 68-72, 1998

A Subcellular Transmissible Agent from Ehrlich Carcinoma Cells Producing Ascites Tumors in Mice. Proceedings. Canadian Cancer Conference 5: 175-189, 1963